Judge rules Walgreens contributed to San Francisco opioid crisis
A federal judge ruled Wednesday that Walgreens "substantially contributed" to San Francisco's opioid epidemic by failing to prevent misuse of the highly addictive painkillers, The Washington Post and San Francisco Chronicle report.
Walgreens handled nearly 1 in 5 oxycodone and hydrocodone pills distributed nationwide at the height of the opioid crisis. It was the only drug company sued by San Francisco that didn't settle. The case went to trial in April.
"Walgreens has regulatory obligations to take reasonable steps to prevent the drugs from being diverted and harming the public," U.S. District Judge Charles Breyer wrote in the ruling. "The evidence at trial established that Walgreens breached these obligations." A later trial will determine how much Walgreens will have to pay the city. A Walgreens spokesperson said the company would appeal.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
Why are home insurance prices going up?
Today's Big Question Climate-driven weather events are raising insurers' costs
By Joel Mathis, The Week US Published
-
'All too often, we get caught up in tunnel vision'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
2024: the year of legacy media failures
In the Spotlight From election criticism to continued layoffs, the media has had it rough in 2024
By Justin Klawans, The Week US Published
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published
-
Enron mystery: 'sick joke' or serious revival?
Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
By Peter Weber, The Week US Published
-
US charges Indian tycoon with bribery, fraud
Speed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
By Peter Weber, The Week US Published
-
Boeing machinists approve contract, end strike
Speed Read The company's largest union approved the new contract offer, ending a seven-week strike
By Peter Weber, The Week US Published
-
US economy still strong in final preelection report
Speed Read It grew at a solid 2.8% annual rate from July through September
By Peter Weber, The Week US Published
-
Boeing machinists reject deal, continue strike
Speed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
By Peter Weber, The Week US Published